Table 1: Comparison between control and chronic hepatitis C patients IL6: Interleukin 6; TNFRI: Tumor Necrosis Factor Receptor I; ALT: Alanine Aminotransferase; AST: Aspartate Aminotransferase; TBil: Total Bilirubin; D.Bill: Direct Bilirubin; INR: International Normalized Ratio of Prothrombin Time of Blood Coagulation; Hb: Hemoglobin; Alb: Albumin; AFP: Alpha Fetoprotein; TSH: Thyroid Stimulating Hormone; BMI: Body Mass Index; WBC: white blood cells. *P< 0.05. |
|||||||
Variable |
Control N=20 |
CHC before treatment N=50 |
P= value |
||||
Mean |
SE |
Mean |
SE |
||||
IL6 (Pg/ml) |
251.2 |
20.624 |
265.97 |
14.855 |
0.585 |
||
TNFRI (Pg/ml) |
22.405 |
6.3556 |
76.394 |
12.4305 |
0.009* |
||
ALT (IU/L) |
32.1 |
1.961 |
59.18 |
2.772 |
0.000* |
||
AST (IU/L) |
35.2 |
2.384 |
62.62 |
3.424 |
0.000* |
||
T BIL (g/dl) |
0.856 |
0.0519 |
1.06 |
0.0579 |
0.049 |
||
D BIL(g/dl) |
0.195 |
0.0352 |
0.254 |
0.0236 |
0.179 |
||
Alb (g/dl) |
3.79 |
0.458 |
3.834 |
0.0461 |
0.578 |
||
INR (%) |
1.198 |
0.0395 |
1.238 |
0.0253 |
0.402 |
||
Glucose (mg/dl) |
110.6 |
3.639 |
99.24 |
2.44 |
0.014* |
||
Hb (g/dl) |
11.8 |
0.408 |
12.01 |
0.258 |
0.662 |
||
TSH (ng/dl) |
2.77 |
0.243 |
3.67 |
0.107 |
0.000* |
||
Serum AFP (ng/ml) |
6.88 |
0.901 |
13.04 |
1.818 |
0.040 |
||
Creatinine(mg/dl) |
0.966 |
0.368 |
0.972 |
0.022 |
0.889 |
||
Platelets |
255100 |
14676.571 |
291.08 |
10.529 |
0.000* |
||
WBC |
5938.75 |
443.571 |
8024 |
197.299 |
0.000* |
||
BMI |
23.3 |
1.318 |
26.98 |
1.334 |
0.110 |